| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1233 | 2022 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 941 | 2017 |
| Cannabis use before age 15 and subsequent executive functioning MA Fontes, KI Bolla, PJ Cunha, PP Almeida, F Jungerman, RR Laranjeira, ... The British Journal of Psychiatry 198 (6), 442-447, 2011 | 368 | 2011 |
| First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ... Molecular psychiatry 11 (2), 118-119, 2006 | 345 | 2006 |
| The role of dopamine in reward and pleasure behaviour–review of data from preclinical research RA Bressan, JA Crippa Acta Psychiatrica Scandinavica 111, 14-21, 2005 | 345 | 2005 |
| A general psychopathology factor (P factor) in children: Structural model analysis and external validation through familial risk and child global executive function. MM Martel, PM Pan, MS Hoffmann, A Gadelha, MC do Rosário, JJ Mari, ... Journal of abnormal psychology 126 (1), 137, 2017 | 283 | 2017 |
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations European Network of National Networks studying Gene-Environment Interactions ... Schizophrenia bulletin 40 (4), 729-736, 2014 | 273 | 2014 |
| High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results GA Salum, A Gadelha, PM Pan, TS Moriyama, AS Graeff‐Martins, ... International journal of methods in psychiatric research 24 (1), 58-73, 2015 | 192 | 2015 |
| Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia WHL Pinaya, A Gadelha, OM Doyle, C Noto, A Zugman, Q Cordeiro, ... Scientific reports 6 (1), 38897, 2016 | 182 | 2016 |
| The impact of epidemic violence on the prevalence of psychiatric disorders in Sao Paulo and Rio de Janeiro, Brazil WS Ribeiro, JJ Mari, MI Quintana, ME Dewey, S Evans-Lacko, LMP Vilete, ... PloS one 8 (5), e63545, 2013 | 172 | 2013 |
| Impact of childhood stress on psychopathology E Brietzke, M Kauer-Sant'anna, A Jackowski, R Grassi-Oliveira, J Bucker, ... Brazilian Journal of Psychiatry 34, 480-488, 2012 | 156 | 2012 |
| Structural validity and reliability of the Positive and Negative Affect Schedule (PANAS): evidence from a large Brazilian community sample HW Carvalho, SB Andreoli, DR Lara, CJ Patrick, MI Quintana, RA Bressan, ... Brazilian Journal of Psychiatry 35, 169-172, 2013 | 150 | 2013 |
| Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial MQ Hoexter, FL de Souza Duran, CC D'alcante, DD Dougherty, ... Neuropsychopharmacology 37 (3), 734-745, 2012 | 148 | 2012 |
| Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients RA Bressan, K Erlandsson, HM Jones, R Mulligan, RJ Flanagan, PJ Ell, ... American Journal of Psychiatry 160 (8), 1413-1420, 2003 | 146 | 2003 |
| Ventral striatum functional connectivity as a predictor of adolescent depressive disorder in a longitudinal community-based sample PM Pan, JR Sato, GA Salum, LA Rohde, A Gadelha, A Zugman, J Mari, ... American Journal of Psychiatry 174 (11), 1112-1119, 2017 | 140 | 2017 |
| Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ... International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015 | 135 | 2015 |
| Towards a multifactorial approach for prediction of bipolar disorder in at risk populations E Brietzke, RB Mansur, JK Soczynska, F Kapczinski, RA Bressan, ... Journal of affective disorders 140 (1), 82-91, 2012 | 133 | 2012 |
| Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ... Psychopharmacology 197, 401-408, 2008 | 132 | 2008 |
| Bitopertin in negative symptoms of schizophrenia—results from the phase III FlashLyte and DayLyte studies D Bugarski-Kirola, T Blaettler, C Arango, WW Fleischhacker, G Garibaldi, ... Biological psychiatry 82 (1), 8-16, 2017 | 119 | 2017 |
| Typical antipsychotic drugs—D2 receptor occupancy and depressive symptoms in schizophrenia RA Bressan, DC Costa, HM Jones, PJ Ell, LS Pilowsky Schizophrenia Research 56 (1-2), 31-36, 2002 | 117 | 2002 |
Jair MariUniversidade Federal de São Paulo在 unifesp.br 的电子邮件经过验证
